Endo International Ordinary Shares reported $8.06B in Loan Capital for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Loan Capital Change
Abbvie ABBV:US $ 63522M 667M
Aerie Pharmaceuticals AERI:US $ 311.68M 77.15M
Amarin AMRN:US $ 0M 0M
Ani Pharmaceuticals ANIP:US $ 286.31M 213K
Bristol Myers Squibb BMY:US $ 37450M 2155M
Coherus Biosciences CHRS:US $ 420.46M 11.68M
Eli Lilly And LLY:US $ 15152.9M 193.5M
Endo International Ordinary Shares ENDP:US $ 8057.5M 9.85M
Heron Therapeutics HRTX:US $ 149.13M 0.05M
Hikma Pharmaceutical HIK:LN 725M 26M
Horizon Pharma HZNP:US $ 2552.74M 2.49M
JAZZ PHA JAZZ:US $ 5992.87M 32.34M
Lannett LCI:US $ 610.08M 6.6M
Ligand Pharmaceuticals LGND:US $ 176.54M 144.18M
Merk MRK:US $ 30586M 104M
Novartis NOVN:VX SF 24373M 150M
Patterson Companies PDCO:US $ 488.35M 0.26M
Phibro Animal Health PAHC:US $ 400.62M 13.3M
Takeda 4502:JP Y 4141418M 90521M
Teva Pharmaceutical TEVA:IT 20.84B 777M
Zoetis ZTS:US $ 5228M 1364M